First Header Logo Second Header Logo

Connection

Martha Alexander-Miller to Vaccinia

This is a "connection" page, showing publications Martha Alexander-Miller has written about Vaccinia.
Connection Strength

1.233
  1. Amoah S, Holbrook BC, Yammani RD, Alexander-Miller MA. High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion. J Immunol. 2013 May 15; 190(10):5020-9.
    View in: PubMed
    Score: 0.444
  2. Yates NL, Yammani RD, Alexander-Miller MA. Dose-dependent lymphocyte apoptosis following respiratory infection with Vaccinia virus. Virus Res. 2008 Nov; 137(2):198-205.
    View in: PubMed
    Score: 0.322
  3. Arimilli S, Palmer EM, Alexander-Miller MA. Loss of function in virus-specific lung effector T cells is independent of infection. J Leukoc Biol. 2008 Mar; 83(3):564-74.
    View in: PubMed
    Score: 0.307
  4. Beauchamp NM, Yammani RD, Alexander-Miller MA. CD8 marks a subpopulation of lung-derived dendritic cells with differential responsiveness to viral infection and toll-like receptor stimulation. J Virol. 2012 Oct; 86(19):10640-50.
    View in: PubMed
    Score: 0.106
  5. Gray PM, Parks GD, Alexander-Miller MA. High avidity CD8+ T cells are the initial population elicited following viral infection of the respiratory tract. J Immunol. 2003 Jan 01; 170(1):174-81.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.